What Can You Expect in 2026?
The 3rd Measuring Patient Engagement Summit is the only industry forum dedicated entirely to answering the million-dollar question: how can biopharma teams objectively measure the impact of patient engagement?
Over three days, you will have the opportunity to join 70+ senior leaders from pharma, biotech, and patient advocacy and explore strategies, frameworks, and practical tools that will transform your well-intentioned engagement into defensible, quantitative evidence.
Through 20+ expert-led sessions, real-world case studies, and hands-on workshops, you will examine approaches to measure the contribution of engagement to protocol design, access strategies, policy influence, and community-level initiatives.
By taking part, you will also experience a dedicated, collaborative session to co-create a practical measurement framework that can be applied in your organization as soon as you return from the conference, alongside guidance on embedding robust metrics into multi-year programs so insights remain visible, credible, and actionable.
This summit provides a rare, non-competitive space to benchmark strategies, collaborate with peers, and acquire practical tools to demonstrate the true value of patient engagement. For teams navigating tighter funding, higher scrutiny, and increasing stakeholder expectations, this is the must-attend event to move from anecdote to evidence, and elevate patient-centric programs into strategic, measurable drivers of impact.
Unmissable Highlights for 2026 Include:
Scaling Patient Engagement Measurement in Biotech Without Big-Pharma Resources
Learn how lean teams can implement high-value measurement strategies without overburdening workflows. Explore approaches to leverage partners, CROs, and patient groups, embed tracking into existing processes, and build foundations that scale as organizations grow.
Building Sustainable, Cross-Functional Systems for Patient Engagement Across Long-Term Trial
Explore how to create cross-functional systems that sustain patient engagement measurement across multi-year clinical programs. Learn strategies to integrate technology, align stakeholders, prioritize meaningful metrics, and embed a culture of continuous improvement - ensuring patient input is consistently tracked, actionable, and informs decision-making across teams.
Driving Smarter Development by Measuring Patient Impact in Pre-Clinical Decision Making
Discover how to capture and quantify patient insights at the earliest stages of development. Identify where patient engagement can influence asset optimization, preclinical strategy, and target value assumptions - and see real-world examples of early input shaping decisions before clinical metrics exist.
Measuring Engagement in Motion: Operational KPIs for Ongoing Clinical Trials
Unlock strategies to monitor patient engagement during live trials. Track recruitment, retention, and site performance, use feedback loops to identify and resolve burden points, and implement mid-trial adjustments that measurably improve adherence, retention, and overall study outcomes.
Translating Patient Insights into Payer Value to Strengthen HTA Outcomes & Launch Readiness
Explore how to convert patient engagement into tangible payer impact. Learn to quantify how patient-driven evidence informs HTA requirements, strengthens value propositions, and supports adoption—turning engagement insights into measurable commercial outcomes and launch readiness.
Co-Creating an Implementable Framework to Measure Patient Engagement Across the Product Lifecycle
Participate in an interactive, hands-on session to turn summit insights into an actionable framework. Apply KPIs across preclinical, clinical, and post-launch stages, link short- and long-term outcomes, and develop a ready-to-use framework that translates engagement activity into measurable value for patients, advocates, regulators, and leadership.
Attending Companies Include